Dr. Robert Gabriel Feldman, MD

Dr. Feldman practices at Feldman Robert G Medical Group in Laguna Hills, California.

Dr. Feldman's NPI, 1194805416, was assigned on October 17, 2006. Dr. Feldman graduated from SUNY Downstate Health Sciences University in 1986. Dr. Feldman holds California license G68484.

Dr. Feldman's primary practice is Feldman Robert G Medical Group, at 23961 Calle De La Magdalena, Laguna Hills, CA 92653-3616. The practice phone is (949) 452-1930.

Dr. Feldman's primary practice is Feldman Robert G Medical Group in Laguna Hills, California. Dr. Feldman is also affiliated with MemorialCare Saddleback Medical Center. Dmand AI also links Dr. Feldman to 1 more hospital and 4 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feldman practices, 7 sites in all. Vendor and product names are available with a free account.

Geriatric medicine is Dr. Feldman's primary specialty in the NPI Registry, under taxonomy code 207RG0300X. Dr. Feldman is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Feldman's licenses on file in 6 states: California, Arizona, Maine, New York, North Carolina and Georgia.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, aneurysm, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Feldman treats.

CMS data shows 25,455 Medicare services from Dr. Feldman across 22 procedure codes in 2024, for 248 Medicare patients. Medicare paid $434,637 for them. Every service was in an office.

CMS counts 248 Medicare patients who saw Dr. Feldman in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feldman's median patient age at 79, with 61% women.

In 2024, Dr. Feldman wrote 8,361 Medicare Part D claims for 394 patients. 92% of them were for generic drugs. CMS names the drug for 7,880 of them, across 110 drugs with 11 or more claims each, at $485,634 in total drug cost. In 2023, CMS named 7,213 claims across 99 drugs.

Dr. Feldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Feldman in 2009. The most frequent topics are Bone Density Conservation Agents, Bone Density and Osteoporosis. Dr. Feldman's most frequent co-authors are Robin K. Dore, MD, Andrew M. Kaunitz, MD and Michael R. Mcclung, MD.

Dmand AI links Dr. Feldman to 6 clinical trials, 2 of them phase 2/3 studies. 1 is still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Cognitive Dysfunction. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Feldman that name 2 trials.

CMS Open Payments shows 2,977 general payments to Dr. Feldman from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Amgen Inc. paid the most, $792,944. It also lists 14 research payments totaling $12,810 from 2017 to 2023, naming 2 clinical trials.

Dr. Feldman graduated from SUNY Downstate Health Sciences University in 1986. Dr. Feldman is a member of ACP.

Dr. Feldman is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.